It should be given as an intravenous (IV) infusion over one hour every four weeks and at least 21 days apart using a sterile, low-protein binding, 0.2 or 0.22 micron in-line filter.
After an initial titration, the recommended dosage is 10 mg/kg body weight Diluted solution should be inspected for particles or discoloration prior to administration.
Stop the infusion upon the first observation of any signs or symptoms consistent with allergic reaction.
• Injection: 300 mg/3 mL (100 mg/mL) in a single-dose vial
• Pregnancy
• Lactation
• Children
After an initial titration, the recommended dosage is 10 mg/kg body weight Diluted solution should be inspected for particles or discoloration prior to administration.
Stop the infusion upon the first observation of any signs or symptoms consistent with allergic reaction.
Dosage & When it is to be taken
Aducanumab is available as: • Injection: 170 mg/1.7 mL (100 mg/mL) in a single-dose vial• Injection: 300 mg/3 mL (100 mg/mL) in a single-dose vial
When it is not to be taken (Contraindications)
• Allergic to Aducanumab• Pregnancy
• Lactation
• Children
